Starpharma is one of Bell Potter top picks for FY18, page-19

Hi @col69,

Doing some research and historically, SPL doesn't tend to increase (or sustain the SP rise) for long after good news......this seemingly just invites profiting day traders. Some of the previous spikes in volume have been from directors buying, a change in notice could be forthcoming if impending partnership deals don't constitute insider trading? Yet I note, none of the board have done any buying this year (Rob Thomas has purchased more BIT though). Looking at the charts, SPL's share price tends to predict good news, it rises slowly in volume and price days prior to a positive price sensitive announcement. Market gave it a shrug of the shoulders after the recent VivaGel trial update, and the bots have been unsuccessful in triggering stop losses. On no news, it's not a day traders dream unlike MSB, yet I feel this is being tightly held at the moment, extracting shares from retail investors has become more and more difficult.....no one wants to miss the BV boat when it departs later this month or stops and picks up passengers (lemmings) in early August.

No predictions from me, mere conjecture, but some strange shenanigans going on.


AG